Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

New Kodak In-Vivo Multispectral Imaging System speeds early disease detection

Carestream Health : 06 February, 2008  (New Product)
Carestream Molecular Imaging, a division of Carestream Health, has introduced a new digital system for fluorescent multispectral optical molecular imaging, enabling researchers to study molecular abnormalities that are the origin of disease at an early stage.
The Kodak In-Vivo Multispectral Imaging System FX, now available worldwide, is designed to precisely locate and monitor changes in molecular activity of specific cells or organs - long before morphological changes can be detected - accelerating the development of effective therapeutics for disease treatment.

In vivo optical molecular imaging allows non-invasive measurement of biological processes within a living organism. A key tenet of this technology is fluorescence, the process in which molecules (within a living organism in the case of in vivo imaging) absorb light, transition from a ground state to an ‘excited’ state, and then emit light of a longer wavelength. Fluorescent imaging techniques can be used to study the cell cycle, signal pathways, gene expressions, and other processes integral to the understanding of disease and therapeutics.

The Kodak In-Vivo Multispectral FX System’s multispectral tuning of excitation light enhances image sensitivity, allowing for the identification and separation of multiple optical (fluorescent) biological marker signals in subjects such as small animals, while removing background noise (autofluorescence).

Sophisticated software, native to the system, automatically generates and analyses a series of images taken at different wavelengths with spatially co-registered X-ray and white light images for improved localization of biomarkers in vivo. The system’s multimodal capabilities include bioluminescence and radioisotopic signal detection, giving researchers a wide range of options for precisely identifying biomarkers of interest in small animals.

“The full release of this system incorporates several years of development work and extensive customer feedback received through our advanced technology placement programme,” said Shahram Hejazi, PhD, president, Carestream Molecular Imaging. “It is the only instrument currently available to provide multispectral fluorescence, luminescence, digital X-ray and radioisotopic imaging capabilities for in vivo imaging. We strongly believe these versatile, powerful capabilities will help facilitate important medical research in the years to come.”

Carestream Molecular Imaging offers a complete line of optical molecular imaging systems designed for a wide range of applications, as well as a complete line of Kodak X-Sight Imaging Agents for both in vivo and in vitro fluorescent applications.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo